In a cohort of 86 primary adenocarcinomas, CD59 protein expression was detected in epithelia of prostate cancer, prostatic intraepithelial neoplasia, benign hyperplasia, atrophic, and normal glands. This evidence concerns the gene CD59 and prostate cancer.